Table 4. Factors associated with survival in patients with HCC associated with NAFLD.
| Characteristics | Local RFS | Systemic RFS |
|---|---|---|
| Age >65 years | 0.501 | 0.544 |
| Male sex | 0.220 | 0.119 |
| Heart disease | 0.453 | 0.513 |
| Hypertension | 0.515 | 0.067 |
| DM | 0.410 | 0.789 |
| Hyperlipidemia | 0.203 | 0.760 |
| Obesity | 0.110 | 0.920 |
| Child-Pugh | 0.735 | 0.715 |
| MELD >10 | 0.956 | 0.600 |
| AFP >20 ng/mL | 0.986 | 0.473 |
| Hypoalbuminemia | 0.796 | 0.338 |
| Thrombocytopenia | 0.920 | 0.659 |
| Major resection | 0.852 | 0.263 |
| Anatomical resection | 0.178 | 0.459 |
| Operation time ≥200 min | 0.402 | 0.322 |
| Blood loss >500 mL | 0.414 | 0.877 |
| Blood transfusion | 0.627 | 0.355 |
| Cirrhosis | 0.117 | 0.375 |
| R0 | 0.428 | 0.715 |
| Microvascular invasion | 0.997 | 0.415 |
| Serosal invasion | 0.696 | 0.085 |
| ES grade | 0.185 | 0.106 |
| T stage | 0.158 | <0.001 |
HCC, hepatocellular carcinoma; NAFLD, non-alcoholic fatty liver disease; RFS, recurrence-free survival; DM, diabetes mellitus; MELD, Model for End-Stage Liver Disease; AFP, α-fetoprotein; ES, Edmonson-Steiner.